• Something wrong with this record ?

Effect of fluoxetine or adenosine receptor NECA agonist on G-proteins of C6 glioma cells or NK immunocytes

H. Kovárů, F. Kovaru, P. Ondráčkova, V. Lisá, A. Fiserová,

. 2011 ; 32 (3) : 274-8.

Language English Country Sweden

Document type Journal Article, Research Support, Non-U.S. Gov't

OBJECTIVE: Neurochemical approaches to antidepressant effects and depressive disorder are also focusing on G-protein coupled receptors (GPCR) and subsequent signalling. Trimeric G-proteins play a crucial role in transmembrane signalling, its amplification and processing. It is evident that immune system participates in antidepressant mode of action by neurotransmitter GPCR. METHODS: We studied the effect of acute administration of fluoxetine or NECA agonist of adenosine receptor (GPCR) on C6 glioma cells and natural killer (NK) cell line, innate immunity. We used immunochemical estimation (ELISA) of the main types of G-protein alpha subunits from isolated membranes of tested cells. RESULTS: Significant reduction of G alpha q/11 subunits after acute administration of fluoxetine or NECA agonist was found. In contrast, no significant influence of G alpha s or G alpha i1,2 subunit levels of C6 glioma cells were observed. Lowered Gq/11 signalling was in accordance with decreased 2nd messenger 1,4,5 IP3 formation by PLC. Acute effect of fluoxetine or NECA agonist on NK cell line resulted in significantly reduced G alpha q/11 levels without changes in G alpha s and G alpha i1,2. Furthermore, we determined that NECA agonist was able to abolish fluoxetine-evoked G alpha q/11 levels of NK cell line. CONCLUSIONS: Results show involvement of fluoxetine in the C6 glioma signal transduction and were comparable with NK cells. Similar inhibiton of G alpha q/11 by NECA agonist in both C6 glioma cells and NK cell line was determined. Furthermore NECA induced attenuation of fluoxetine evoked Galpha q/11 signalling can indicate parallel interference between GPCR and final response. Finally, we determined similarity in both interleukin 2, IL2 immunostimulator and fluoxetine evoked G q/11 levels in NK cell line and thus fluoxetine action could be related to signalling aspects of neuroimmunomodulatory activity.

000      
00000naa a2200000 a 4500
001      
bmc12027479
003      
CZ-PrNML
005      
20121210095550.0
007      
ta
008      
120817s2011 sw f 000 0#eng||
009      
AR
035    __
$a (PubMed)21712787
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sw
100    1_
$a Kovárů, Hana $u 1st Faculty of Medicine, Charles University in Prague, Prague, Czech Republic. hkovaru@cesnet.cz
245    10
$a Effect of fluoxetine or adenosine receptor NECA agonist on G-proteins of C6 glioma cells or NK immunocytes / $c H. Kovárů, F. Kovaru, P. Ondráčkova, V. Lisá, A. Fiserová,
520    9_
$a OBJECTIVE: Neurochemical approaches to antidepressant effects and depressive disorder are also focusing on G-protein coupled receptors (GPCR) and subsequent signalling. Trimeric G-proteins play a crucial role in transmembrane signalling, its amplification and processing. It is evident that immune system participates in antidepressant mode of action by neurotransmitter GPCR. METHODS: We studied the effect of acute administration of fluoxetine or NECA agonist of adenosine receptor (GPCR) on C6 glioma cells and natural killer (NK) cell line, innate immunity. We used immunochemical estimation (ELISA) of the main types of G-protein alpha subunits from isolated membranes of tested cells. RESULTS: Significant reduction of G alpha q/11 subunits after acute administration of fluoxetine or NECA agonist was found. In contrast, no significant influence of G alpha s or G alpha i1,2 subunit levels of C6 glioma cells were observed. Lowered Gq/11 signalling was in accordance with decreased 2nd messenger 1,4,5 IP3 formation by PLC. Acute effect of fluoxetine or NECA agonist on NK cell line resulted in significantly reduced G alpha q/11 levels without changes in G alpha s and G alpha i1,2. Furthermore, we determined that NECA agonist was able to abolish fluoxetine-evoked G alpha q/11 levels of NK cell line. CONCLUSIONS: Results show involvement of fluoxetine in the C6 glioma signal transduction and were comparable with NK cells. Similar inhibiton of G alpha q/11 by NECA agonist in both C6 glioma cells and NK cell line was determined. Furthermore NECA induced attenuation of fluoxetine evoked Galpha q/11 signalling can indicate parallel interference between GPCR and final response. Finally, we determined similarity in both interleukin 2, IL2 immunostimulator and fluoxetine evoked G q/11 levels in NK cell line and thus fluoxetine action could be related to signalling aspects of neuroimmunomodulatory activity.
650    _2
$a adenosin-5'-(N-ethylkarboxamid) $x farmakologie $7 D019830
650    _2
$a zvířata $7 D000818
650    _2
$a antidepresiva tricyklická $x farmakologie $7 D000929
650    _2
$a nádory mozku $x metabolismus $7 D001932
650    _2
$a nádorové buněčné linie $7 D045744
650    _2
$a ELISA $7 D004797
650    _2
$a fluoxetin $x farmakologie $7 D005473
650    _2
$a proteiny vázající GTP $x metabolismus $7 D019204
650    _2
$a gliom $x metabolismus $7 D005910
650    _2
$a lidé $7 D006801
650    _2
$a imipramin $x farmakologie $7 D007099
650    _2
$a imunologické faktory $x farmakologie $7 D007155
650    _2
$a interleukin-2 $x metabolismus $7 D007376
650    _2
$a buňky NK $x účinky léků $x metabolismus $7 D007694
650    _2
$a krysa rodu Rattus $7 D051381
650    _2
$a potkani inbrední F344 $7 D011916
650    _2
$a selektivní inhibitory zpětného vychytávání serotoninu $x farmakologie $7 D017367
650    _2
$a signální transdukce $x účinky léků $7 D015398
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Kovaru, Frantisek
700    1_
$a Ondráčkova, Petra
700    1_
$a Lisá, Vĕra
700    1_
$a Fiserová, Anna
773    0_
$w MED00168352 $t Neuro endocrinology letters $x 0172-780X $g Roč. 32, č. 3 (2011), s. 274-8
856    41
$u https://pubmed.ncbi.nlm.nih.gov/21712787 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y m
990    __
$a 20120817 $b ABA008
991    __
$a 20121210095626 $b ABA008
999    __
$a ok $b bmc $g 949521 $s 784825
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2011 $b 32 $c 3 $d 274-8 $i 0172-780X $m Neuro-endocrinology letters $n Neuro-endocrinol. lett. $x MED00168352
LZP    __
$a Pubmed-20120817/11/03

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...